Expression of human α(1,3)fucosyltransferase antisense sequences inhibits selectin-mediated adhesion and liver metastasis of colon carcinoma cells

Cancer Research

Volumn 59, Issue 9, 1999, Pages 2127-2135

  Weston, Brent W ^a   Hiller, Kara M ^a   Mayben, John P ^a   Manousos, George A ^a   Bendt, Katharine M ^a   Liu, Rong ^a   Cusack Jr , James C ^a  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTISENSE OLIGONUCLEOTIDE; ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; FUCOSYLTRANSFERASE; SIALOGLYCOPROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL ADHESION; COLON CARCINOMA; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN CELL; LIVER METASTASIS; METASTASIS INHIBITION; MOUSE; NONHUMAN; NUDE MOUSE; PRIORITY JOURNAL; SPLEEN;

ADENOCARCINOMA; ANIMALS; ANTIGENS, NEOPLASM; CELL ADHESION; CELLS, CULTURED; COLONIC NEOPLASMS; DISEASE PROGRESSION; DNA, ANTISENSE; E-SELECTIN; ENDOTHELIUM, VASCULAR; FEMALE; FUCOSYLTRANSFERASES; GANGLIOSIDES; GENETIC VECTORS; GLYCOSYLATION; HUMANS; INJECTIONS; LIVER NEOPLASMS; MICE; MICE, NUDE; NEOPLASM PROTEINS; NEOPLASM TRANSPLANTATION; OLIGOSACCHARIDES; PROTEIN PROCESSING, POST-TRANSLATIONAL; SPLEEN; TRANSFECTION; TUMOR CELLS, CULTURED;

EID: 0033135594     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (79)

1. Lasky, L. Selectins: interpreters of cell-specific carbohydrate information during inflammation. Science (Washington DC), 258: 964-969, 1992.
2. Sass, P. M. The involvement of selectins in cell adhesion, tumor progression, and metastasis. Cancer Invest., 16: 322-328, 1998.
3. Takada, A., Ohmori, K., Takahasho, N., Tsuyuoka, K., Yago, K., Zenita, K., Hasegawa, A., and Kannagi, R. Adhesion of human cancer cells to vascular endothelium mediated by a carbohydrate antigen, sialyl Lewis A. Biochem Biophys. Res. Commun., 179: 713-719, 1991.
4. Takada, A., Ohmori, K., Yoneda, T., Tsuyuoka, K., Hasegawa, A., Kiso, M., and Kannagi, R. Contribution of carbohydrate antigens sialyl Lewis A and sialyl Lewis X to adhesion of human cancer cells to vascular endothelium. Cancer Res., 53: 354-361, 1993.
5. x, and sulfated glycans modulate this binding. Biochem. Biophys. Res. Commun., 181: 1223-1230, 1991.
6. Schadendorf, D., Heidel, J., Gawlik, C., Suter, L., and Czarnetzki, B. M. Association with clinical outcome of expression of VLA-4 in primary cutaneous malignant melanoma as well as P-selectin and E-selectin on intratumoral vessels. J. Natl. Cancer Inst., 87: 366-371, 1995.
7. x determinant of myeloid and tumor cells. Science (Washington DC), 250: 1132-1135, 1990.
8. Srinivas, U., Pahlsson, P., and Lundblad, A. E-selectin/sialyl Lewis a-dependent adhesion of colon cancer cells is inhibited differently by antibodies against E-selectin ligands. Scand. J. Immunol., 44: 197-203, 1996.
9. Morikawa, K., Walker, S. M., Jessup, J. M., and Fidler, I. J. In vivo selection of highly metastatic cells from surgical specimens of different primary human colon carcinomas implanted into nude mice. Cancer Res., 48: 1943-1948, 1988.
10. Kuo, T. H., Kubota, T., Watanabe, M., Furukawa, T., Teramoto, T., Ishbiki, K., Kitajima, M., Moossa, A. R., Penman, S., and Hoffman, R. H. Liver colonization competence governs colon cancer metastasis. Proc. Natl. Acad. Sci. USA, 92: 12085-12089, 1995.
11. Biancone, L., Araki, M., Araki, K., Vassalli, P., and Stamenkovic, I. Redirection of tumor metastasis by expression of E-selectin in vivo. J. Exp. Med., 183: 581-587, 1996.
12. Siegel, G., and Malmsten, M. The role of the endothelium in inflammation and tumor metastasis. Int J. Microcirc. Clin. Exp., 17: 257-272, 1997.
13. McEver, R. P. Selectin-mediated interactions during inflammation and metastasis. Glycoconjugate J., 14: 585-591, 1997.
14. Nowacki, M. P., Janik, P., and Nowacki, P. M. Inflammation and metastases. Med. Hypotheses, 47: 193-195, 1996.
15. Fukuda, M. Possible roles of tumor-associated carbohydrate antigens. Cancer Res., 56: 2237-2244, 1996.
16. Renkonen, R., Mattila, P., Majuri, M. L., Rabina, J., Toppila, S., Renkonen, J., Hirvas, L., Niittymaki, J., Turunen, J. P., Renkonen, O., and Paavoenen, T. In vitro experimental studies of sialyl Lewis x and sialyl Lewis a on endothelial and carcinoma cells: crucial glycans on selectin ligands. Glycoconjugate J., 14: 593-600, 1997.
17. x carbohydrate antigen: liver colonization and adhesion to vascular endothelial cells. Exp. Cell Res., 216: 215-221, 1995.
18. Yamada, N., Chung, Y. S., Takatsuka, S., Arimoto, Y., Sawada, T., Dohl, T., and Sowa, M. Increased sialyl Lewis A expression and fucosyltransferase activity with acquisition of a high metastatic capacity in a colon cancer cell line. Br. J. Cancer, 76: 582-587, 1997.
19. a antigen. Int. J. Cancer, 69: 290-294, 1996.
20. Pleskow, D. K., Berger, H. J., Gyves, J., Allen, E., McLean, A., and Podolsky, D. K. Evaluation of a serologic marker, CA19-9, in the diagnosis of pancreatic cancer. Ann. Intern. Med., 110: 704-709, 1989.
21. Herlyn, M., Sears, H. F., Verrill, H., and Koprowski, H. Increased sensitivity in detecting tumor-associated antigens in sera of patients with colorectal carcinoma. J. Immunol. Methods, 75: 15-21, 1984.
22. Kuusela, P., Jalanko, H., Roberts, P., Sipponen, P., Mecklin, J. P., Pitkanen, R., and Makela, O. Comparison of CA 19-9 and carcinoembryonic antigen (CEA) levels in the serum of patients with colorectal diseases. Br. J. Cancer, 49: 135-139, 1984.
23. Hoff, S., Irimura, T., Matsushita, Y., Ota, D., Cleary, K., and Hakomori, S. Metastatic potential of colon carcinoma. Expression of ABO/Lewis-related antigens. Arch. Surg., 125: 206-209, 1990.
24. Nakamori, S., Kameyama, M., Imaoka, S., Furukawa, H., Ishikawa, O., Sasaki, Y., Kabuto, T., Iwanaga, T., Matsushita, Y., and Irimura, T. Increased expression of sialyl Lewis x antigen correlates with poor survival in patients with colorectal carcinoma. Cancer Res., 53: 3632-3637, 1993.
25. x expression in gastric carcinoma correlates with venous invasion and poor outcome. Gastroenterology, 114: 462-470, 1998.
26. Yamada, N., Chung, Y-S., Maeda, K., Sawada, T., Ikehara, T., Nishino, H., Okuno, M., and Sowa, M. Increased expression of sialyl Lewis A and sialyl Lewis X in liver metastases of human colorectal carcinoma. Invasion Metastasis, 15: 95-102, 1995.
27. Kuijipers, T. Terminal glycosyltransferase activity: a selective role in cell adhesion. Blood, 81: 873-882, 1993.
28. Candelier, J. J., Mollicone, R., Mennesson, B., Bergemer, A. M., Henry, S., Couillin, P., and Oriol, R. Alpha-3-fucosyltransferases and their glycoconjugate antigen products in the developing human kidney. Lab. Invest., 69: 449-459, 1993.
29. Stroup, G. B., Anumula, K. R., Kline, T. F., and Caltabiano, M. M. Identification and characterization of two distinct α-(1-3)-L-fucosyltransferase activities in human colon carcinoma. Cancer Res., 50: 6787-6792, 1990.
30. Mollicone, R., Candelier, J. J., Mennesson, B., Couillin, P., Venot, A. P., and Oriol, R. Five specificity patterns of (1-3)-α-L-fucosyltransferase activity defined by use of synthetic oligosaccharide acceptors. Carbohydr. Res., 228: 265-276, 1992.
31. Macher, B. A., Holmes, E. H., Swiedler, S. J., Stults, C. L. M., and Srnka, C. A. Human α(1,3)fucosyltransferases. Glycobiology, 6: 577-584, 1991.
32. Mollicone, R., Candelier, J., Reguigne, I., Couillin, P., Fletcher, A., and Oriol R. Molecular genetics of α-L-fucosyltransferase genes (H, Se, Le, FUT4, FUT5, and FUT6). Transfus. Clin. Biol., 2: 91-97, 1994.
33. Kukowska-Latallo, J. F., Larsen, R. D., Nair, R. P., and Lowe, J. B. A cloned human cDNA determines expression of a mouse stage-specific embryonic antigen and the Lewis blood group α(1,3/1,4)fucosyltransferase. Genes Dev., 4: 1288-1303, 1990.
34. Goelz, S. E., Hession, C., Goff, D., Griffiths, B., Tizaed, R., Newman, B., Chi-Rosso, G., and Lobb, R. ELFT: a gene that directs the expression of an ELAM-1 ligand. Cell, 63: 1349-1356, 1990.
35. Lowe, J. B., Kukowska-Latallo, J. F., Nair, R. P., Larsen, R. D., Marks, R. M., Macher, B. A., Kelly, R., and Ernst, L. K. Molecular cloning of a human fucosyltransferase gene that determines expression of the Lewis x and Vim-2 epitopes but not ELAM-1-dependent cell adhesion. J. Biol. Chem., 260: 17467-17477, 1991.
36. Kumar, R., Potvin, B., Muller, W. A., and Stanley, P. Cloning of a human α(1,3)-fucosyltransferase gene that encodes ELFT but does not confer ELAM-1 recognition on Chinese hamster ovary cell transfectants. J. Biol. Chem., 266: 21777-21783, 1991.
37. Weston, B.W., Nair, R. P., Larsen, R. D., and Lowe, J. B. Isolation of a novel human α(1,3)fucosyltransferase gene and molecular comparison to the human Lewis blood group α(1,3/1,4)fucosyltransferase. J. Biol. Chem., 267: 4152-4160, 1992.
38. Weston, B. W., Smith, P. L., Kelly, R. J., and Lowe, J. B. Molecular cloning of a fourth member of a human α(1,3)fucosyltransferase gene family. J. Biol. Chem., 267: 24575-24584, 1992.
39. Koszdin, K. L., and Bowen, B. R. The cloning and expression of a human α-1,3 fucosyltransferase capable of forming the E-selectin ligand. Biochem. Biophys. Res. Commun., 187: 152-157, 1992.
40. Sasaki, K., Kurata, K., Funayama, K., Nagata, M., Watanabe, E., Ohta, S., Hanai, N., and Nishi, T. Expression cloning of a novel α(1,3)-fucosyltransferase that is involved in biosynthesis of the sialyl Lewis x carbohydrate determinants in leukocytes. J. Biol. Chem., 269: 14730-14737, 1994.
41. Natsuka, S., Gersten, K., Zenita, K., Kannagi, R., and Lowe, J. B. Molecular cloning of a cDNA encoding a novel human leukocyte α-1,3-fucosyltransferase capable of synthesizing the sialyl Lewis x determinant. J. Biol. Chem., 269: 16789-16794, 1994.
42. Cameron, H. S., Szczepaniak, D. A., and Weston, B. W. Expression of human chromosome 19p α(1,3)fucosyltransferase genes in normal tissues: alternative splicing, polyadenylation, and isoforms. J. Biol. Chem., 270: 20112-20122, 1995.
43. Yago, K., Zenita, K., Ginya, H., Sawada, M., Ohmori, K., Minoru, O., Kannagi, R., and Lowe, J. Expression of α-(1,3)-fucosyltransferases which synthesize sialyl Le(x) and sialyl Le(a), the carbohydrate ligands for E- and P-selectins in human malignant cell lines. Cancer Res., 53: 5559-5565, 1993.
44. Mannori, G., Crottet, P., Cecconi, O., Hanasaki, K., Aruffo, A., Nelson, R. M., Varki, A., and Bevilacqua, M. P. Differential colon cancer cell adhesion to E-, P-, and L-seleclin: role of mucin-type glycoproteins. Cancer Res., 55: 4425-4431, 1995.
45. Majuri, M. L., Niemela, R., Tiisala, S., Renkonen, O., and Renkonen, R. Expression and function of alpha 2,3-sialyl- and alpha 1,3/1,4-fucosyltransferases in colon adenocarcinoma cell lines: role in synthesis of E-selectin counter-receptors. Int. J. Cancer, 63: 551-559, 1995.
46. Price, J. E., Daniels, L. M., Campbell, D. E., and Giavazzi, R. Organ distribution of experimental metastases of a human colorectal carcinoma injected in nude mice. Clin. Exp. Metastasis, 7: 55-68, 1989.
47. Yoshida, K., Rivoire, M. L., Divgi, C. R., Niedzwiechi, D., Cohen, A. M., and Sigurdson, E. R. Effect of tumor size on monoclonal antibody uptake in a metastatic model. J. Surg. Oncol., 49: 249-252, 1992.
48. Gewirtz, A. M., Stein, C. A., and Glazer, P. M. Facilitating oligonucleotide delivery: helping antisense deliver on its promise. Proc. Natl. Acad. Sci. USA, 93: 3161-3163, 1996.
49. Long, L., Rubin, R., Baserga, R., and Brodt, P. Loss of the metastatic phenotype in murine carcinoma cells expressing an antisense RNA to the insulin-like growth factor receptor. Cancer Res., 55: 1006-1009, 1995.
50. Sierakowska, H., Sambade, M. J., Agrawl, S., and Kole, R. Repair of thalassemic human β-globin mRNA in mammalian cells by antisense oligonucleoutides. Proc. Natl. Acad. Sci. USA, 93: 12840-12844, 1996.
51. Romer, L. H., McLean, N., Turner, C. E., and Burridge, K. Tyrosine kinase activity, cytoskeletal organization, and motility in human vascular endothelial cells. Mol. Biol. Cell., 5: 349-361, 1994.
52. Mollicone, R., Reguigne, I., Kelly, R. J., Fletcher, A., Watt, J., Chatfield, S., Aziz, A., Cameron, H. S., Weston, B. W., Lowe, J. B., and Oriol, R. Molecular basis for Lewis α(1,3/1,4)fucosyltransferase gene deficiency in Lewis negative Indonesian pedigrees. J. Biol. Chem., 269: 20987-20994, 1994.
53. Lowe, J. B., Stoolman, L. M., Nair, R. P., Larsen, R. D., Berhend, T., and Marks, R. M. ELAM1-dependent cell adhesion to vascular endothelium determined by a transfected human fucosyltransferase cDNA. Cell, 63: 475-484, 1990.
54. x. Science (Washington DC), 250: 1130-1132, 1990.
55. Chen, C. J., Li, L. J., Maruya, A., and Shively, J. E. In vitro and in vivo footprint analysis of the promoter of carcinoembryonic antigen in colon carcinoma cells: effects of interferon treatment. Cancer Res., 55: 3873-3882, 1995.
56. Grimm, T., and Johnson J. P. Ectopic expression of carcinoembryonic antigen by a melanoma cell leads to changes in the transcription of two additional cell adhesion molecules. Cancer Res., 55: 3254-3257, 1995.
57. Obrink, B. CEA adhesion molecules: multifunctional proteins with signal-regulatory properties. Curr. Opin. Cell Biol., 9: 616-626, 1997.
58. Zbar, A. P., Lemoine, N. R., Wadhwa, M., Thomas, H., Snary, D., and Kmiot, W. A. Biological therapy: approaches in colorectal cancer. Br. J. Cancer, 77: 683-693, 1998.
59. Stanners, C. P., DeMarte, L., Rojas, M., Gold, P., and Fuks, A. Opposite functions for two classes of genes of the human carcinoembryonic antigen family. Tumor Biol., 16: 23-31, 1995.
60. Sawada, R., Tsuboi, S., and Fukuda. M. Differential E-selectin-dependent adhesion efficiency in sublines of a human colon cancer exhibiting distinct metastatic potentials. J. Biol. Chem., 269: 1425-1431, 1994.
61. Buckhaults, P., Chen, L., Fregien, N., and Pierce, M. Transcriptional regulation of N-acetylglucosaminyltransferase V by the src oncogene. J. Biol. Chem., 272: 19575-19581, 1997.
62. Wojciechowiccz, D. C., Park, P. Y., and Paly, P. B. Beta 1-6 branching of N-linked carbohydrate is associated with K-ras mutation in human colon carcinoma cell lines. Biochem. Biophys. Res. Commun., 212: 758-66, 1995.
63. Dong, J. T., Lamb, P. W., Rinker-Schaeffer, J. V., Ichikawa, T., Isaacs, J. T., and Barrett, J. C. KAI 1: a metastasis suppressor gene for prostate cancer on human chromosome11p11.2. Science (Washington DC), 268: 884-886, 1995.
64. Guo, X., Friess, H., Graber, H. U., Kashiwagi, M., Zimmerman, A., Korc, M., and Buchler, M. W. KAI 1 expression is up-regulated in early pancreatic cancer and decreased in the presence of metastases. Cancer Res., 56: 4876-4880, 1996.
65. Steegmaier, M., Levinovitz, A., Isenmann, S., Borges, E., Lenter, M., Kocher, H. P., Kleuser, B., and Vesteber, D. The E-selectin-ligand ESL-1 is a variant of a receptor for fibroblast growth factor. Nature (Lond.), 373: 615-620, 1995.
66. Norman, K. E., Moore, K. L., McEver, R. P., and Ley, K. Leukocyte rolling in vivo is mediated by P-selectin glycoprotein ligand-1. Blood, 12: 4417-4421, 1995.
67. Wilkins, P. P., McEver, R. P., and Cummings, R. D. Structures of the O-glycans on P-selectin glycoprotein ligand-1 from HL-60 cells. J. Biol. Chem., 271: 18732-18742, 1996.
68. Feizi, T. Demonstration by monoclonal antibodies that carbohydrate structures of glycoproteins and glycolipids are oncodevelopmental antigens. Nature (Lond.), 314: 53-57, 1985.
69. Hakomori, S. Glycosphingolipids as differentiation-dependent, tumor-associated markers and as regulators of cell proliferation. Trends Biochem. Sci., 9: 453-456, 1984.
70. Hauck, W., and Stanners, C. P. Transcriptional regulation of the carcinoembryonic antigen gene. Identification of regulatory elements and multiple nuclear factors. J. Biol. Chem., 270: 3602-3610, 1995.
71. Hilton, E., Chandrasekaran, V., Rindos, P., and Isenberg, H. D. Association of recurrent candidal vaginitis with inheritance of Lewis blood group antigens. J. Infect. Dis., 172: 1616-1619, 1995.
72. Green, D., Jarrett, O., Ruth, K. J., Folsom, A. R., and Liu, K. Relationship among Lewis phenotype, clotting factors, and other cardiovascular risk factors in young adults. J. Lab. Clin. Med., 125: 334-339, 1995.
73. Orntoft, T. F., Holmes, E. H., Johnson, P., Hakomri, S., and Clausen, H. Differential tissue expression of the Lewis blood group antigens: enzymatic, immunohistologic. and immunochemical evidence for Lewis a and b antigen expression in Le (a-b-) individuals. Blood, 77: 1389-1396, 1991.
74. Cheng, J. Q., Ruggeri, B., Klein, W. M., Sonoda, G., Altomare, D. A., Watson, D. K., and Testa, J. R. Amplification of AKT2 in human pancreatic cancer cells and inhibition of AKT2 expression and tumorigenicity by antisense RNA. Proc. Natl. Acad. Sci. USA, 93: 3636-3641, 1996.
75. Phillips, J. A., Craig, S. J., Bayley, D., Christian, R. A., Geary, R., and Nicklin, P. L. Pharmacokinetics, metabolism, and elimination of a 20-mer phosphorothioate oligodeoxynucleotide (CGP 69846A) after intravenous and subcutaneous administration. Biochem. Pharmacol., 54: 657-668, 1997.
76. Hughes, J. A., Aronsohn, A. I., Avrutskaya, A. V., and Juliano, R. L. Evaluation of adjuvants that enhance the effectiveness of antisense oligodeoxynucleotides. Pharm. Res., 13: 404-410, 1995.
77. Jain, R. K. Delivery of molecular medicine to solid tumors. Science (Washington DC), 271: 1079-1080, 1996.
78. Lewis, J. G., Lin, K. Y., Kothavale, A., Flanagan, W. M., Matteucci, M. D., DePrince, R. B., Mook, R. A., Hendren, R. W., and Wagner, R. W. A serum-resistant cytofectin for cellular delivery of antisense oligodeoxynucleotides and plasmid DNA. Proc. Natl. Acad. Sci. USA, 93: 3176-3181, 1996.
79. Tonkinson, J. L., and Stein, C. A. Antisense oligodeoxynucleotides as clinical therapeutic agents. Cancer Invest., 14: 54-65, 1996.